Characterization of Adherent Bacteroidales from Intestinal Biopsies of Children and Young Adults with Inflammatory Bowel Disease

There is extensive evidence implicating the intestinal microbiota in inflammatory bowel disease [IBD], but no microbial agent has been identified as a sole causative agent. Bacteroidales are numerically dominant intestinal organisms that associate with the mucosal surface and have properties that both positively and negatively affect the host. To determine precise numbers and species of Bacteroidales adherent to the mucosal surface in IBD patients, we performed a comprehensive culture based analysis of intestinal biopsies from pediatric Crohn's disease [CD], ulcerative colitis [UC], and control subjects. We obtained biopsies from 94 patients and used multiplex PCR or 16S rDNA sequencing of Bacteroidales isolates for species identification. Eighteen different Bacteroidales species were identified in the study group, with up to ten different species per biopsy, a number higher than demonstrated using 16S rRNA gene sequencing methods. Species diversity was decreased in IBD compared to controls and with increasingly inflamed tissue. There were significant differences in predominant Bacteroidales species between biopsies from the three groups and from inflamed and uninflamed sites. Parabacteroides distasonis significantly decreased in inflamed tissue. All 373 Bacteroidales isolates collected in this study grew with mucin as the only utilizable carbon source suggesting this is a non-pathogenic feature of this bacterial order. Bacteroides fragilis isolates with the enterotoxin gene [bft], previously associated with flares of colitis, were not found more often at inflamed colonic sites or within IBD subjects. B. fragilis isolates with the ability to synthesize the immunomodulatory polysaccharide A [PSA], previously shown to be protective in murine models of colitis, were not detected more often from healthy versus inflamed tissue.

[1]  S. Cox,et al.  Microbiota Separation and C-reactive Protein Elevation in Treatment-naïve Pediatric Granulomatous Crohn Disease , 2012, Journal of pediatric gastroenterology and nutrition.

[2]  Eric J. Alm,et al.  Non-Invasive Mapping of the Gastrointestinal Microbiota Identifies Children with Inflammatory Bowel Disease , 2012, PloS one.

[3]  S. Hasnain,et al.  Mucins in inflammatory bowel diseases and colorectal cancer , 2012, Journal of gastroenterology and hepatology.

[4]  P. Adamski,et al.  Horizontal Distribution of the Fecal Microbiota in Adolescents With Inflammatory Bowel Disease , 2012, Journal of pediatric gastroenterology and nutrition.

[5]  P. Allen,et al.  Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. , 2011, Cell host & microbe.

[6]  P. Moayyedi,et al.  Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis , 2011, The American Journal of Gastroenterology.

[7]  L. Comstock,et al.  Longitudinal Analysis of the Prevalence, Maintenance, and IgA Response to Species of the Order Bacteroidales in the Human Gut , 2011, Infection and Immunity.

[8]  T. Hudcovic,et al.  Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition , 2011, Clinical and experimental immunology.

[9]  Julian Parkhill,et al.  High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease , 2011, BMC Microbiology.

[10]  Michael A McGuckin,et al.  Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria , 2010, The American Journal of Gastroenterology.

[11]  A. Verma,et al.  Real-Time Analysis of Mucosal Flora in Patients with Inflammatory Bowel Disease in India , 2010, Journal of Clinical Microbiology.

[12]  P. Lepage,et al.  Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. , 2010, Journal of medical microbiology.

[13]  C. Josenhans,et al.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models , 2010, Nature Reviews Microbiology.

[14]  Katja G. Weinacht,et al.  Trans locus inhibitors limit concomitant polysaccharide synthesis in the human gut symbiont Bacteroides fragilis , 2010, Proceedings of the National Academy of Sciences.

[15]  M. Surette,et al.  Effects of mesalamine (5‐aminosalicylic acid) on bacterial gene expression , 2009, Inflammatory bowel diseases.

[16]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[17]  C. Sears Enterotoxigenic Bacteroides fragilis: a Rogue among Symbiotes , 2009, Clinical Microbiology Reviews.

[18]  D. Golenbock,et al.  Induction of Persistent Colitis by a Human Commensal, Enterotoxigenic Bacteroides fragilis, in Wild-Type C57BL/6 Mice , 2009, Infection and Immunity.

[19]  A. Opekun,et al.  Rising Incidence of Inflammatory Bowel Disease Among Children: A 12-year Study , 2010, Journal of pediatric gastroenterology and nutrition.

[20]  S. Mazmanian,et al.  A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.

[21]  J. Gordon,et al.  IgA response to symbiotic bacteria as a mediator of gut homeostasis. , 2007, Cell host & microbe.

[22]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[23]  A. Griffiths,et al.  Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. , 2007, Gastroenterology.

[24]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[25]  H. Lochs,et al.  Azathioprine and mesalazine‐induced effects on the mucosal flora in patients with IBD colitis , 2007, Inflammatory bowel diseases.

[26]  U. Gophna,et al.  Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative Colitis , 2006, Journal of Clinical Microbiology.

[27]  J. Satsangi,et al.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.

[28]  S. Miehlke,et al.  Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. , 2006, Journal of medical microbiology.

[29]  S. Cucchiara,et al.  Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease , 2006, Gut.

[30]  P. Eckburg Molecular Analysis of the Colonic Mucosal Microbiota in Patients with Crohn’s Disease , 2005 .

[31]  S. Mazmanian,et al.  An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.

[32]  H. Lochs,et al.  Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease , 2005, Journal of Clinical Microbiology.

[33]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[34]  Alexandra Bazeos,et al.  Are Helicobacter Species and Enterotoxigenic Bacteroides fragilis Involved in Inflammatory Bowel Disease? , 2004, Digestive Diseases and Sciences.

[35]  J. Hampe,et al.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.

[36]  H. Harmsen,et al.  Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice , 2003, Gut.

[37]  S. Finegold,et al.  Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers. , 2003, FEMS microbiology letters.

[38]  Jeffrey I. Gordon,et al.  Angiogenins: a new class of microbicidal proteins involved in innate immunity , 2003, Nature Immunology.

[39]  E. Zoetendal,et al.  Mucosa-Associated Bacteria in the Human Gastrointestinal Tract Are Uniformly Distributed along the Colon and Differ from the Community Recovered from Feces , 2002, Applied and Environmental Microbiology.

[40]  C. Neut,et al.  Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease , 2002, American Journal of Gastroenterology.

[41]  Laurie E. Comstock,et al.  Extensive surface diversity of a commensal microorganism by multiple DNA inversions , 2001, Nature.

[42]  D. Kasper,et al.  Polysaccharide Biosynthesis Locus Required for Virulence of Bacteroides fragilis , 2001, Infection and Immunity.

[43]  J. Gordon,et al.  Molecular analysis of commensal host-microbial relationships in the intestine. , 2001, Science.

[44]  D. Kasper,et al.  Genetic Diversity of the Capsular Polysaccharide C Biosynthesis Region of Bacteroides fragilis , 2000, Infection and Immunity.

[45]  Yajarayma J. Tang,et al.  Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. , 2000, Emerging infectious diseases.

[46]  A. Franco,et al.  Identification of a Third Metalloprotease Toxin Gene in Extraintestinal Isolates of Bacteroides fragilis , 1999, Infection and Immunity.

[47]  K. Wilson,et al.  Differential Induction of Colitis and Gastritis in HLA-B27 Transgenic Rats Selectively Colonized with Bacteroides vulgatus or Escherichia coli , 1999, Infection and Immunity.

[48]  D. Kasper,et al.  Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates , 1995, Journal of clinical microbiology.

[49]  P. Rutgeerts,et al.  Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. , 1995, Gastroenterology.

[50]  C. Hart,et al.  A novel mucin sulphatase from human faeces: its identification, purification and characterization. , 1992, Clinical science.

[51]  J T Boyle,et al.  Development and validation of a pediatric Crohn's disease activity index. , 1991, Journal of pediatric gastroenterology and nutrition.

[52]  D. Jewell,et al.  Role of the faecal stream in the maintenance of Crohn's colitis. , 1985, Gut.

[53]  M. P. Bryant,et al.  Nutritional features of Bacteroides fragilis subsp. fragilis. , 1974, Applied microbiology.

[54]  M. Faure,et al.  Multifaceted transcriptional regulation of the murine intestinal mucus layer by endogenous microbiota. , 2008, Genomics.